| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.00097 | 1 |
| mRNA | BIBW2992 | FIMM | pan-cancer | AAC | -0.0035 | 1 |